12.07.2015 Views

drug coverage criteria – new and therapeutic equivalent medications

drug coverage criteria – new and therapeutic equivalent medications

drug coverage criteria – new and therapeutic equivalent medications

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

COVERAGE RATIONALEThis policy provides information <strong>and</strong> <strong>criteria</strong> relevant to <strong>medications</strong> for which certain types ofprescription <strong>drug</strong> benefit exclusions may apply.In accordance with Oxford's prescription <strong>drug</strong> riders, certain <strong>medications</strong> are excluded from<strong>coverage</strong>. The rationale for such exclusions varies, <strong>and</strong> therefore <strong>coverage</strong> may be provided incertain clinical scenarios.There are two types of exclusions addressed in this policy:Exclude at Launch: In an effort to enhance the affordability <strong>and</strong> value of prescription<strong>drug</strong> riders, <strong>and</strong> as part of our Prescription Drug List (PDL) management, Oxford willproactively identify <strong>and</strong> help manage the cost of low value <strong>medications</strong> being introducedinto the market. The Exclude at Launch program delays <strong>coverage</strong> until a full evaluationcan be completed for <strong>new</strong> <strong>medications</strong> that may offer little to no additional health carevalue. Our PDL Management Committee will review each Exclude at Launch medicationto determine its tier placement or benefit <strong>coverage</strong>.Same Active Ingredient: Oxford may exclude <strong>coverage</strong> for a medication, unless it ismedically necessary for the member, if it includes the same active ingredient (or amodified version of an active ingredient) <strong>and</strong> is <strong>therapeutic</strong>ally <strong>equivalent</strong> to a coveredprescription medication. Oxford's definition of <strong>therapeutic</strong> equivalence refers to<strong>medications</strong> that produce the same <strong>therapeutic</strong> outcome <strong>and</strong> adverse event profile.The following table provides a list of prescription <strong>medications</strong> for which one or both of the aboveexclusions apply. Precertification through the Pharmacy Benefit Manager (PBM) is requiredfor all listed <strong>medications</strong>. Coverage will be provided only when Member has exhibitedintolerance (that is, sensitivity, <strong>drug</strong> allergy, adverse effect) to, or experienced a <strong>therapeutic</strong>failure with, the covered formulary alternative(s) noted below.Medication/DrugFormulary Alternative(s)Absoricaisotretinoin (generic Accutane), Amnesteem, Claravis,Myorisan, SotretAcuvailKetorolacAdoxa 150mg (Br<strong>and</strong>)Doxycycline 50 mg or 100mgAlsumasumatriptan injectionAltoprevLovastatin (generic Mevacor)AmrixCyclobenzaprine HCL(generic for Flexeril)AmturnideAmlodipine + Tekturna HCT (or individual components takenconcomitantly)Analpram Advanced KitHydrocortisone acetate/pramoxine HCl, Analpram HCAndrogelTestimAplenzinBuproprion XL (generic for Wellbutrin XL)Aqua Glycolilc HCHydrocortisone 2.5% (generic Hytone)Aricept (23 mg only)donepezil 10mg (generic for Aricept 10mg)Asacol HDAsacolAsmalPredPrednisolone sodium phosphate (generic Orapred)AsmalPred Plusprednisolone sodium phosphate (generic Orapred)Astelin (br<strong>and</strong> only)Azelastine nasal spray (generic Astelin), AsteproAtelviaActonelAugmentin XR / Amoxicillin-Clavulanate Amoxicillin/clavulanate potassium (generic for Augmentin)ERAuralgan 5.5%/1.4%Antipyrine/benzocaine solution – 5.4%/1.4% (genericAuralgan)Auvi-QEpiPen, EpiPen Jr.Drug Coverage Criteria - New <strong>and</strong> Therapeutic Equivalent Medications: Clinical Policy (Effective 04/01/2013)©1996-2013, Oxford Health Plans, LLC2

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!